|Reference : Purification and Biochemical Characterization of Recombinant Human Placental Growth Horm...|
|Scientific journals : Article|
|Life sciences : Biochemistry, biophysics & molecular biology|
|Purification and Biochemical Characterization of Recombinant Human Placental Growth Hormone Produced in Escherichia Coli|
|Igout, Ahmed [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques >]|
|Van Beeumen, Jozef [> > > >]|
|Frankenne, Francis [Université de Liège - ULg > Département des sciences cliniques > Département des sciences cliniques >]|
|Scippo, Marie-Louise [Université de Liège - ULg > Département de sciences des denrées alimentaires > Analyse des denrées alimentaires >]|
|DEVREESE, Bart [> > > >]|
|Hennen, Georges [Centre Hospitalier Universitaire de Liège - CHU > > Endocrinologie clinique >]|
|Yes (verified by ORBi)|
|[en] trvhPGH ; Ecoli ; mass seoectroscopy|
|[en] The hGH-V (or hGH-2) gene codes for human placental growth hormone (hPGH). Secretion of hPGH is continuous, in contrast with the pulsed secretion of pituitary growth hormone (hGH) which it progressively replaces in the maternal bloodstream. hGH- V cDNA has previously been cloned and isolated. Analysis of its nucleotide sequence has revealed a 191-residue protein, hPGH, differing from hGH at 13 positions. The calculated pI is more basic than that of the pituitary hormone. Here we have inserted hGH- VcDNA into the pIN-III-ompA3 plasmid in order to produce hPGH in its native form in Escherichia coli D1210. Expression of hGH- V cDNA in E. coli is significantly lower than that of hGH cDNA with the same expression system. The hPGH produced in E. coli was purified in quantities sufficient to allow its biochemical and immunochemical characterization. The molecular mass of the protein was determined by electrospray m.s. The determined mass, 22320 Da, agrees well with the molecular mass calculated from the translated cDNA sequence, assuming the presence of two disulphide bridges. Having established the technique for producing hPGH with a primary structure identical to the natural, non-glycosylated, 22 kDa isoform, we can now plan the full physicochemical and pharmaceutical characterization of this new hormonal entity.|
|Researchers ; Professionals ; Students|
There is no file associated with this reference.
All documents in ORBi are protected by a user license.